PRF Technologies (PRFX) Net Cash Flow Growth (3y) (2023 - 2024)

PRF Technologies (PRFX) Net Cash Flow Growth (3y) (2023 - 2024) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	NCF Growth (3y) (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-28.90%
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-5.41%
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	19.55%
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	95.24%
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-106.21%
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	4.40%
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	17.73%
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	PRF Technologies	654,452.72	-3.49 Mn	-	-

Download Data